Immunomodulators acting as antagonists of PD-1
US-11066445-B2 · Jul 20, 2021 · US
This page is not indexed by search engines while we improve data quality.
Mull Eric patents
Mull Eric is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mull Eric |
| Total patents | 40 |
| First publication | Feb 17, 2015 |
| Latest publication | Jul 20, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Indazole derivatives as alpha v integrin antagonists
US-11028071-B2 · Jun 8, 2021 · US
Indazole derivatives as alpha v integrin antagonists
US-2020339540-A1 · Oct 29, 2020 · US
Indazole derivatives as αv integrin antagonists
US-10745384-B2 · Aug 18, 2020 · US
Compounds useful as immunomodulators
US-10745382-B2 · Aug 18, 2020 · US
Immunomodulators acting as antagonists of pd-1
US-2020172578-A1 · Jun 4, 2020 · US
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
US-10538555-B2 · Jan 21, 2020 · US
Immunomodulators
US-10450347-B2 · Oct 22, 2019 · US
Indazole derivatives as alpha v integrin antagonists
US-2019256496-A1 · Aug 22, 2019 · US
Immunomodulators
US-10358463-B2 · Jul 23, 2019 · US
Recent patents
Latest publications not already listed above.
Immunomodulators
US-10143746-B2 · Dec 4, 2018 · US
Compounds useful as immunomodulators
US-10144706-B2 · Dec 4, 2018 · US
Immunomodulators
US-9944678-B2 · Apr 17, 2018 · US
Compounds useful as immunomodulators
US-2018057455-A1 · Mar 1, 2018 · US
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
US-9879046-B2 · Jan 30, 2018 · US
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
US-2017369530-A1 · Dec 28, 2017 · US
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
US-9850283-B2 · Dec 26, 2017 · US
Immunomodulators
US-2017283463-A1 · Oct 5, 2017 · US
Immunomodulators
US-2017283462-A1 · Oct 5, 2017 · US
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
US-2017260237-A1 · Sep 14, 2017 · US
Immunomodulators
US-2017252432-A1 · Sep 7, 2017 · US
Immunomodulators
US-9732119-B2 · Aug 15, 2017 · US
Compounds useful as immunomodulators
US-2017107202-A1 · Apr 20, 2017 · US
Macrocyclic compounds as HCV entry inhibitors
US-9624245-B2 · Apr 18, 2017 · US
Hepatitis C virus inhibitors
US-9598433-B2 · Mar 21, 2017 · US
Hepatitis C virus inhibitors
US-9527885-B2 · Dec 27, 2016 · US
Macrocyclic Inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 Protein/Protein Interactions
US-2016340391-A1 · Nov 24, 2016 · US
Hepatitis C virus inhibitors
US-9499550-B2 · Nov 22, 2016 · US
Immunomodulators
US-2016272680-A1 · Sep 22, 2016 · US
Immunomodulators
US-2016222060-A1 · Aug 4, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 40 |
| Hiebert Sheldon | 1 |
| Rajamani Ramkumar | 1 |
| Sun Li-Qiang | 1 |
| Mull Eric | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.